Compare Merck & Co., Inc. (MRK) vs ThredUp Inc (TDUP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs ThredUp Inc — how do they compare? Merck & Co., Inc. trades at $135.31 (market cap $327.94B), while ThredUp Inc trades at $3.17 (market cap $405.82M). The key difference: Merck & Co., Inc. is far larger — about 808.1× ThredUp Inc's market cap, and Merck & Co., Inc. pays a 2.56% dividend while ThredUp Inc pays none. Which is the better fit depends on your goals.
| MRK | TDUP | |
|---|---|---|
Market Cap | $327.94B | $405.82M |
Sector | Health | Consumer Cyclical |
52-Week High | $132.93 | $12.08 |
52-Week Low | $77.60 | $3.08 |
Enterprise Value | $374.70B | $404.00M |
Dividend Yield | 2.56% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MRK trades at $135.55, up 3.91% today, near its consensus price target of $140.58. The stock shows bullish technical momentum with strong moving average signals, though RSI levels indicate potential overbought conditions. Recent earnings beats and a 67.57% analyst buy rating reflect positive sentiment. The acquisition of Terns Pharmaceuticals for approximately $6.7 billion (Business Wire, 2026-04-07) aims to bolster its oncology pipeline, while steady revenue growth and a 28.07% net income margin in 2025 underscore fundamental strength.
Outlook remains favorable with strategic M&A and earnings consistency, but risks include high valuation multiples (P/E of 106.34) and competitive pressures in pharma. The stock offers growth potential from pipeline expansion, yet investors face headwinds from debt increases and market volatility. Upside to the $155 high target depends on successful integration and sustained profitability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About ThredUp Inc
ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners.
Read more on TDUP →
